GSA Capital Partners’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

GSA Capital Partners’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-50,240	Closed	-$2.12M	–	2254
2015 Q2	$2.12M	Buy	50,240 +14,082	+39%	+$594K	0.08%	331
2015 Q1	$1.4M	Buy	36,158 +9,892	+38%	+$381K	0.06%	610
2014 Q4	$884K	Sell	26,266 -13,400	-34%	-$473K	0.06%	551
2014 Q3	$1.39M	Buy	39,666 +9,400	+31%	+$322K	0.07%	331
2014 Q2	$995K	Buy	30,266 +9,178	+44%	+$314K	0.04%	680
2014 Q1	$777K	Sell	21,088 -5,200	-20%	-$191K	0.06%	469
2013 Q4	$1.01M	Sell	26,288 -12,446	-32%	-$393K	0.08%	350
2013 Q3	$1.06M	Buy	38,734 +3,829	+11%	+$90.7K	0.08%	318
2013 Q2	$733K	Buy	+34,905	New	+$681K	0.09%	348

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

GSA Capital Partners's WX Position: Q3 2015 in Review

GSA Capital Partners sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 50,240 shares — an estimated $2.12M sold.

GSA Capital Partners first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $2.12M in Q2 2015. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

GSA Capital Partners reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
GSA Capital Partners sold 50,240 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $2.12M.
GSA Capital Partners first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
GSA Capital Partners's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.12M in Q2 2015.
151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on GSA Capital Partners's 13F filing for Q3 2015, filed 13 Nov 2015.